Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy

Journal of Clinical Microbiology

Volumn 43, Issue 10, 2005, Pages 5316-5318

  Perz, Joseph F ^a,e   Craig, Allen S ^b   Stratton, Charles W ^c   Bodner, Stanley J ^c   Phillips Jr , Walter E ^d   Schaffner, William ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b TENNESSEE DEPARTMENT OF HEALTH   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTENNIAL MEDICAL CENTER   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRESERVATIVE; HEPARIN;

ARTICLE; ASEPSIS; BACTERIAL GROWTH; CASE REPORT; COLONY FORMING UNIT; DRUG FORMULATION; DRUG STERILITY; HOSPITAL PHARMACY; HUMAN; LAVAGE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PSEUDOMONAS PUTIDA; PULSED FIELD GEL ELECTROPHORESIS; QUALITY CONTROL; SEPTICEMIA;

BACTEREMIA; DRUG COMPOUNDING; DRUG CONTAMINATION; HEPARIN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NURSERIES; PHARMACY SERVICE, HOSPITAL; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PUTIDA; SODIUM CHLORIDE;

BACTERIA (MICROORGANISMS); PSEUDOMONAS PUTIDA;

EID: 26944490332     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.10.5316-5318.2005     Document Type: Article

References (17)

1. American Society of Health System Pharmacists. 1993. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am. J. Hosp. Pharm. 50:2386-2398.
2. American Society of Health System Pharmacists. 2000. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am. J. Health Syst. Pharm. 57:1150-1169.
3. Anonymous. 1999. Chapter 1140-7. Sterile product preparation in pharmacy practice, p. 1-6. In Rules of the Tennessee Board of Pharmacy. Tennessee Department of State, Nashville.
4. Bouallegue, O., R. Mzoughi, F. X. Weill, N. Mahdhaoui, Y. Ben Salem, H. Sboui, F. Grimont, and P. A. Grimont. 2004. Outbreak of Pseudomonas putida bacteraemia in a neonatal intensive care unit. J. Hosp. Infect. 57:88-91.
5. Brady M.T., and R. D. Feigin. 2005. Pseudomonas and related species, p. 1401-1413, In J. Fletcher (ed.), Textbook of pediatric infectious diseases, 4th ed. W. B. Saunders, Philadelphia, Pa.
6. CDC. 1986. Reported contamination of heparin sodium with Pseudomonas putida. Morb. Mortal. Wkly. Rep. 35:123-124.
7. CDC. 2005. Pseudomonas bloodstream infections associated with a heparin/saline flush-Missouri, New York, Texas, and Michigan, 2004-2005. Morb. Mortal. Wkly. Rep. 54:269-272.
8. Hiller, J. L. 1986. Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants. Pediatrics 77:500-506.
9. Jardine, D. S., and K. Rogers. 1989. Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants. Pediatrics 83:153-160.
10. Kastango, E. S., and B. D. Bradshaw. 2004. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am. J. Health Syst. Pharm. 61:1928-1938.
11. Ladhani S., and Z. A. Bhutta. 1998. Neonatal Pseudomonas putida infection presenting as staphylococcal scalded skin syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 17:642-644.
12. Maslow J. N., A. M. Slutsky, and R. D. Arbeit. 1993. Application of pulsed-field gel electrophoresis to molecular epidemiology, p. 563-572. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
13. Morris, A. M., P. J. Schneider, C. A. Pedersen, and J. M. Mirtallo. 2003. National survey of quality assurance activities for pharmacy-compounded sterile preparations. Am. J. Health Syst. Pharm. 60:2567-2576.
14. Myers, C. E. 1996. Needed: serious attention to sterile products. Am. J. Health Syst. Pharm. 53:2582.
15. NCCLS. 1999. Methods for determining bactericidal activity of antimicrobial agents: approved guideline. M26-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Talley, C. R. 2003. Sterile compounding in hospital pharmacies. Am. J. Health Syst. Pharm. 60:2563.
17. Yang, C. H., T. Young, M. Y. Peng, and M. Weng. 1996. Clinical spectrum of Pseudomonas putida infection. J. Formos. Med. Assoc. 95:754-761.